DK662787A - Anvendelse af en 5-ht-receptorantagonist - Google Patents

Anvendelse af en 5-ht-receptorantagonist

Info

Publication number
DK662787A
DK662787A DK662787A DK662787A DK662787A DK 662787 A DK662787 A DK 662787A DK 662787 A DK662787 A DK 662787A DK 662787 A DK662787 A DK 662787A DK 662787 A DK662787 A DK 662787A
Authority
DK
Denmark
Prior art keywords
anagonist
receptor
methyl
carbazol
imidazol
Prior art date
Application number
DK662787A
Other languages
Danish (da)
English (en)
Other versions
DK662787D0 (da
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK662787D0 publication Critical patent/DK662787D0/da
Publication of DK662787A publication Critical patent/DK662787A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
DK662787A 1986-12-17 1987-12-16 Anvendelse af en 5-ht-receptorantagonist DK662787A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (2)

Publication Number Publication Date
DK662787D0 DK662787D0 (da) 1987-12-16
DK662787A true DK662787A (da) 1988-06-18

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK662787A DK662787A (da) 1986-12-17 1987-12-16 Anvendelse af en 5-ht-receptorantagonist

Country Status (18)

Country Link
US (1) US4835173A (de)
EP (1) EP0276559B1 (de)
JP (1) JP2732844B2 (de)
KR (1) KR880007073A (de)
AT (1) ATE79031T1 (de)
AU (1) AU608794B2 (de)
CY (1) CY1693A (de)
DE (1) DE3780940T2 (de)
DK (1) DK662787A (de)
ES (1) ES2051754T3 (de)
GB (1) GB8630071D0 (de)
GR (1) GR3005682T3 (de)
HK (1) HK36593A (de)
IE (1) IE60135B1 (de)
IL (1) IL84844A0 (de)
NZ (1) NZ222949A (de)
PH (1) PH25503A (de)
ZA (1) ZA879458B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
JPS63277622A (ja) * 1986-12-17 1988-11-15 グラクソ、グループ、リミテッド 医薬
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア,インコーポレーテッド 光学的に純粋なr(+)オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
CA2371822A1 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
ES2204358T1 (es) * 2000-10-30 2004-05-01 Teva Pharmaceutical Industries Ltd. Nuevas formas de cristal y de disolvente de hidrocloruro de ondasetron y procedimientos para su preparacion.
EP1207160A1 (de) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Verfahren zur Herstellung von 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
ZA200305338B (en) * 2001-01-11 2004-07-12 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate.
AU2003223764A1 (en) * 2002-04-29 2003-11-17 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
AU2003223763A1 (en) * 2002-04-30 2003-11-17 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
EP2186517A4 (de) * 2007-08-08 2010-08-18 Ibanez Juan Jose Legarda Verwendung und anwendungsverfahren für einen serotin3-rezeptor (5-ht3)-antagonisten und selektiven chloridkanalmodulator zur behandlung von sucht bzw. abhängigkeit von arzneimitteln/drogen oder erkrankungen des nervensystems
CA3102307A1 (en) * 2018-06-21 2019-12-26 Societe Des Produits Nestle S.A. Compositions and methods using a nicotinamide adenine dinucleotide (nad+) precursor and at least one ketone or ketone precursor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (de) * 1981-06-09 1987-02-28 Ici Plc
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
IE57809B1 (en) * 1984-01-25 1993-04-21 Glaxo Group Ltd 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
EP0201165B1 (de) * 1985-03-14 1994-07-20 Beecham Group Plc Arzneimittel zur Behandlung von Emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions

Also Published As

Publication number Publication date
DE3780940T2 (de) 1992-12-24
JP2732844B2 (ja) 1998-03-30
GB8630071D0 (en) 1987-01-28
AU8261787A (en) 1988-06-23
US4835173A (en) 1989-05-30
DE3780940D1 (de) 1992-09-10
CY1693A (en) 1994-01-14
EP0276559A3 (en) 1989-10-18
NZ222949A (en) 1997-06-24
EP0276559A2 (de) 1988-08-03
EP0276559B1 (de) 1992-08-05
IE60135B1 (en) 1994-06-01
IE873415L (en) 1988-06-17
PH25503A (en) 1991-07-24
ZA879458B (en) 1988-11-30
JPS63165314A (ja) 1988-07-08
AU608794B2 (en) 1991-04-18
DK662787D0 (da) 1987-12-16
HK36593A (en) 1993-04-23
ES2051754T3 (es) 1994-07-01
IL84844A0 (en) 1988-06-30
KR880007073A (ko) 1988-08-26
ATE79031T1 (de) 1992-08-15
GR3005682T3 (de) 1993-06-07

Similar Documents

Publication Publication Date Title
DK662787D0 (da) Anvendelse af en 5-ht-receptorantagonist
FR2658414B1 (fr) Implant pour dispositif d'osteosynthese en particulier du rachis.
ES2079620T3 (es) Protesis femoral parcialmente cimentada.
SE8503680D0 (sv) Indolderivat
ATE269290T1 (de) Benzoylderivate
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
FR2670669B1 (fr) Instrument de correction chirurgicale de l'astigmatisme.
DE69107329D1 (de) Zahnärztliches Handstück.
FR2681779B1 (fr) Ancillaire pour la mise en place d'une prothese de plateau tibial.
DK612787D0 (da) Anvendelse af imidazolderivater
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
GR3003327T3 (en) Substituted 1,8-naphthyridine derivatives and fungicides containing them
IT8919074A0 (it) Composizione per l'igiene orale.
IT1286299B1 (it) Porta impronte per protesi dentali fisse.
ITBO910103U1 (it) Dispositivo per realizzare attacchi rapidi per protesi dentarie.
ATE219083T1 (de) 4-oxo-und 4h-imidazo(5,1-c)(1,4)benzoxazine nützlich als benzodiazepinrezeptor-bindemittel.
DE69223362D1 (de) N1-Trifluoralkyl substituierte 2-Nitro-p-Phenylendiaminfarbstoffe
FR2670665B1 (fr) Moyen d'ancrage radiculaire pour prothese dentaire.
FR2666979B3 (fr) Dispositif pour deposer des couronnes, protheses ou bridges dentaires.
IT1192045B (it) Articolatore d'anca per protesi ortopediche
IT1217080B (it) Acetabolo perfezionato per protesi d'anca.
IT8821443A0 (it) Cotile per protesi d'anca.
FR2651673B1 (fr) Positionneur prothetique pour l'art dentaire.
IT206741Z2 (it) Bastoncino per l'igiene del canale uditivo.
IT1238934B (it) Attacco per protesi dentale rimovibile, con ritenzione regolabile

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment